Resultats de la cerca - Guérette, Benoît

Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study per Haraoui, Boulos, Cividino, Alfred, Stewart, Jacqueline, Guérette, Benoît, Keystone, Edward C

Obtenir text complet Obtenir text complet Obtenir text complet

Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis per Landewé, Robert, Smolen, Josef S, Florentinus, Stefan, Chen, Su, Guérette, Benoît, van der Heijde, Désirée

Obtenir text complet Obtenir text complet Obtenir text complet

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoi... per Kavanaugh, Arthur, Fleischmann, Roy M, Emery, Paul, Kupper, Hartmut, Redden, Laura, Guerette, Benoit, Santra, Sourav, Smolen, Josef S

Obtenir text complet Obtenir text complet Obtenir text complet

Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn’s disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s Disea... per Panaccione, Remo, Loftus, Edward V, Binion, David, McHugh, Kevin, Alam, Shamsul, Chen, Naijun, Guérette, Benoît, Mulani, Parvez, Chao, Jingdong

Obtenir text complet Obtenir text complet

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1–3 pooled analysis per Kavanaugh, Arthur, Gladman, Dafna D., Edwards, Christopher J., Schett, Georg, Guerette, Benoit, Delev, Nikolay, Teng, Lichen, Paris, Maria, Mease, Philip J.

Obtenir text complet Obtenir text complet Obtenir text complet

Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid art... per Kavanaugh, Arthur, van Vollenhoven, Ronald F, Fleischmann, Roy, Emery, Paul, Sainsbury, Iain, Florentinus, Stefan, Chen, Su, Guérette, Benoît, Kupper, Hartmut, Smolen, Josef S

Obtenir text complet Obtenir text complet Obtenir text complet

Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled Trials per Mease, Philip J., Gladman, Dafna D., Kavanaugh, Arthur, McGonagle, Dennis, Nash, Peter, Guerette, Benoit, Nakasato, Priscila, Brunori, Michele, Teng, Lichen, McInnes, Iain B.

Obtenir text complet Obtenir text complet Obtenir text complet

Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations per Mease, Philip J., Gladman, Dafna D., Ogdie, Alexis, Coates, Laura C., Behrens, Frank, Kavanaugh, Arthur, McInnes, Iain, Queiro, Rubén, Guerette, Benoit, Brunori, Michele, Teng, Lichen, Smolen, Josef S.

Obtenir text complet Obtenir text complet Obtenir text complet

Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimu... per Smolen, Josef S, van der Heijde, Désirée M, Keystone, Edward C, van Vollenhoven, Ronald F, Goldring, Mary B, Guérette, Benoît, Cifaldi, Mary A, Chen, Naijun, Liu, Shufang, Landewé, Robert B M

Obtenir text complet Obtenir text complet Obtenir text complet

Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies per Gladman, Dafna D, Kavanaugh, Arthur, Gómez-Reino, Juan J, Wollenhaupt, Jürgen, Cutolo, Maurizio, Schett, Georg, Lespessailles, Eric, Guerette, Benoit, Delev, Nikolay, Teng, Lichen, Edwards, Christopher J, Birbara, Charles A, Mease, Philip J

Obtenir text complet Obtenir text complet Obtenir text complet